TY - JOUR
T1 - A Randomized Clinical Trial to Assess the Effect of Statins on Skeletal Muscle Function and Performance
T2 - Rationale and Study Design
AU - Thompson, Paul D.
AU - Parker, Beth A.
AU - Clarkson, Priscilla M.
AU - Pescatello, Linda S.
AU - Michael White, C.
AU - Grimaldi, Adam S.
AU - Levine, Benjamin D.
AU - Haller, Ronald G.
AU - Hoffman, Eric P.
PY - 2010/6
Y1 - 2010/6
N2 - Hydroxymethylglutaryl-coenzyme A reductase inhibitors or statins are the most effective medications for reducing elevated concentrations of low-density lipoprotein cholesterol (LDL-C). Statins reduce cardiac events in patients with coronary artery disease and previously healthy persons. Current recommendations for LDL-C treatment goals indicate that more patients will be treated with higher doses of these medications. Statins have been extremely well-tolerated in controlled clinical trials but are increasingly recognized to produce skeletal muscle myalgia, cramps, and weakness. The reported frequency of such mild symptoms is not clear, and muscle performance has not been examined with these medications. Accordingly, the present investigation, the Effect of Statins on Skeletal Muscle Function and Performance (STOMP) study, will recruit approximately 440 healthy persons. Participants will be randomly assigned to treatment with atorvastatin 80 mgd or placebo. Handgrip, elbow and knee isometric and isokinetic strength, knee extensor endurance, and maximal aerobic exercise performance will be determined at baseline. Participants will undergo repeat testing after 6 months of treatment or after meeting the study definition of statin myalgia. This study will determine the effect of statins on skeletal muscle strength, endurance, and aerobic exercise performance and may ultimately help clinicians better evaluate statin-related muscle and exercise complaints.
AB - Hydroxymethylglutaryl-coenzyme A reductase inhibitors or statins are the most effective medications for reducing elevated concentrations of low-density lipoprotein cholesterol (LDL-C). Statins reduce cardiac events in patients with coronary artery disease and previously healthy persons. Current recommendations for LDL-C treatment goals indicate that more patients will be treated with higher doses of these medications. Statins have been extremely well-tolerated in controlled clinical trials but are increasingly recognized to produce skeletal muscle myalgia, cramps, and weakness. The reported frequency of such mild symptoms is not clear, and muscle performance has not been examined with these medications. Accordingly, the present investigation, the Effect of Statins on Skeletal Muscle Function and Performance (STOMP) study, will recruit approximately 440 healthy persons. Participants will be randomly assigned to treatment with atorvastatin 80 mgd or placebo. Handgrip, elbow and knee isometric and isokinetic strength, knee extensor endurance, and maximal aerobic exercise performance will be determined at baseline. Participants will undergo repeat testing after 6 months of treatment or after meeting the study definition of statin myalgia. This study will determine the effect of statins on skeletal muscle strength, endurance, and aerobic exercise performance and may ultimately help clinicians better evaluate statin-related muscle and exercise complaints.
UR - http://www.scopus.com/inward/record.url?scp=77955216028&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955216028&partnerID=8YFLogxK
U2 - 10.1111/j.1751-7141.2009.00063.x
DO - 10.1111/j.1751-7141.2009.00063.x
M3 - Article
C2 - 20626664
AN - SCOPUS:77955216028
SN - 1520-037X
VL - 13
SP - 104
EP - 111
JO - Preventive Cardiology
JF - Preventive Cardiology
IS - 3
ER -